These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20227286)

  • 1. Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study.
    Madani K; Zhao R; Lim HJ; Casson AG
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1427-32. PubMed ID: 20227286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
    Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
    Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
    Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity is not associated with adverse outcome following surgical resection of oesophageal adenocarcinoma.
    Madani K; Zhao R; Lim HJ; Casson SM; Casson AG
    Eur J Cardiothorac Surg; 2010 Nov; 38(5):604-8. PubMed ID: 20444616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
    Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 Mutations in carcinoma of the esophagus and gastroesophageal junction.
    Sengpiel C; König IR; Rades D; Noack F; Duchrow M; Schild SE; Ludwig D; Homann N
    Cancer Invest; 2009 Jan; 27(1):96-104. PubMed ID: 19160092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].
    Muzeau F; Fléjou JF; Potet F; Belghiti J; Thomas G; Hamelin R
    Gastroenterol Clin Biol; 1996; 20(5):430-7. PubMed ID: 8761140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study.
    Langer R; Mutze K; Becker K; Feith M; Ott K; Höfler H; Keller G
    J Clin Pathol; 2010 Nov; 63(11):994-8. PubMed ID: 20924032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
    Makino T; Yamasaki M; Miyata H; Yoshioka S; Takiguchi S; Fujiwara Y; Nakajima K; Nishida T; Mori M; Doki Y
    Ann Surg Oncol; 2010 Mar; 17(3):804-11. PubMed ID: 19885698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
    Chang SC; Lin JK; Lin TC; Liang WY
    Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus.
    Heeren PA; Kloppenberg FW; Hollema H; Mulder NH; Nap RE; Plukker JT
    Anticancer Res; 2004; 24(4):2579-83. PubMed ID: 15330218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of p53 protein overexpression in patients with node-negative lung adenocarcinoma.
    Suzuki H; Kawaguchi T; Hasegawa T; Yonechi A; Ohsugi J; Higuchi M; Yamada F; Shio Y; Fujiu K; Kanno R; Ohishi A; Gotoh M
    Cancer Lett; 2006 Jun; 237(2):242-7. PubMed ID: 16102896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis.
    Kim H; Song JY; Cho JY; Yoon YS; Han HS; Lee HS; Ryu HS; Choe G
    J Clin Pathol; 2010 Dec; 63(12):1048-53. PubMed ID: 20924037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between p53 nuclear protein accumulation and mutations of the p53 gene in human esophageal cancer from linxian].
    Liang Y; Lu S; Guo Y
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):412-4. PubMed ID: 8697989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors.
    Barbour AP; Jones M; Brown I; Gotley DC; Martin I; Thomas J; Clouston A; Smithers BM
    Ann Surg Oncol; 2010 Sep; 17(9):2494-502. PubMed ID: 20349213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.